GlassScriptPhysician profile
Jamil A Hossain
NPI 1225384209
$5,558.35
in general payments reported to CMS, 2019-2025
22 companies · $685 in 2025
The $685 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $709 · 2020: $273 · 2021: $2,507 · 2022: $636 · 2023: $444 · 2024: $304 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,433.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,150.48 | 2021-2025 | Prostep Mica, N/A, Variax |
| Smith+Nephew, INC. | $1,638.62 | 2019-2025 | Grafix, Stravix, Collagenase Santyl |
| Kerecis Limited | $686.56 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $277.78 | 2025 | |
| Integra Lifesciences Corporation | $153.35 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $149.43 | 2019-2022 | |
| Osiris Therapeutics INC. | $108.17 | 2019 | |
| Averitas Pharma INC. | $72.85 | 2025 | Qutenza |
| Horizon Therapeutics Plc | $42.66 | 2019-2020 | |
| Nevro Corp. | $30.98 | 2023 | Senza |
| Acumed LLC | $30.20 | 2025 | Acumed |
| Misonix INC | $27.62 | 2019 | |
| Polynovo North America LLC | $27.15 | 2024 | Novosorb Btm |
| Zyla Life Sciences, INC. | $22.99 | 2019-2020 | |
| Bioventus LLC | $22.46 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $22.25 | 2020-2021 | |
| Music City Medical Technologies, LLC | $18.79 | 2025 | |
| Acera Surgical, INC. | $18.36 | 2019 | |
| Boston Scientific Corporation | $18.02 | 2024 | Wavewriter Alpha Prime 16 |
| Wright Medical Technology, INC. | $14.24 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.38 | 2023 | Nuzyra |
| Alfasigma USA, INC. | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamil Hossain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.